Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124946713 | 12494671 | 3 | F | 2016 | 20160920 | 20160624 | 20160928 | EXP | JP-009507513-1606JPN008656 | MERCK | 79.00 | YR | M | Y | 62.10000 | KG | 20160928 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124946713 | 12494671 | 1 | PS | REBETOL | RIBAVIRIN | 1 | Oral | 200 MG, BID | Y | 20903 | 200 | MG | CAPSULE | BID | |||||
| 124946713 | 12494671 | 2 | SS | REBETOL | RIBAVIRIN | 1 | Y | 20903 | CAPSULE | ||||||||||
| 124946713 | 12494671 | 3 | SS | SOVALDI | SOFOSBUVIR | 1 | Oral | 400 MG, QD | Y | 0 | 400 | MG | TABLET | QD | |||||
| 124946713 | 12494671 | 4 | SS | SOVALDI | SOFOSBUVIR | 1 | Y | 0 | TABLET | ||||||||||
| 124946713 | 12494671 | 5 | C | MAGLAX (magnesium oxide) | MAGNESIUM OXIDE | 1 | Oral | 500 MG, TID | U | U | 0 | 500 | MG | TABLET | TID | ||||
| 124946713 | 12494671 | 6 | C | MAGLAX (magnesium oxide) | MAGNESIUM OXIDE | 1 | Oral | 660 MG, TID | U | U | 0 | 660 | MG | TABLET | TID | ||||
| 124946713 | 12494671 | 7 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Oral | 2 MG, QD | U | U | 0 | 2 | MG | TABLET | QD | ||||
| 124946713 | 12494671 | 8 | C | TRAZENTA | LINAGLIPTIN | 1 | Oral | 5 MG, QD | U | U | 0 | 5 | MG | TABLET | QD | ||||
| 124946713 | 12494671 | 9 | C | BAYASPIRIN | ASPIRIN | 1 | Oral | 100 MG, QD | U | U | 0 | 100 | MG | TABLET | QD | ||||
| 124946713 | 12494671 | 10 | C | FEBURIC | FEBUXOSTAT | 1 | Oral | 10 MG, QD | U | U | 0 | 10 | MG | TABLET | QD | ||||
| 124946713 | 12494671 | 11 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 5 MG, QD | U | U | 0 | 5 | MG | TABLET | QD | ||||
| 124946713 | 12494671 | 12 | C | BETANIS | MIRABEGRON | 1 | Oral | 50 MG, QD | U | U | 0 | 50 | MG | TABLET | QD | ||||
| 124946713 | 12494671 | 13 | C | CILNIDIPINE | CILNIDIPINE | 1 | Oral | 10 MG, BID | U | U | 0 | 10 | MG | TABLET | BID | ||||
| 124946713 | 12494671 | 14 | C | MICARDIS | TELMISARTAN | 1 | Oral | 40 MG, BID | U | U | 0 | 40 | MG | TABLET | BID | ||||
| 124946713 | 12494671 | 15 | C | ADALAT CC | NIFEDIPINE | 1 | Oral | 10 MG, BID | U | U | 0 | 10 | MG | TABLET | BID | ||||
| 124946713 | 12494671 | 16 | C | MOHRUS L | KETOPROFEN | 1 | Topical | 40 MG, QD | U | U | 0 | 40 | MG | QD | |||||
| 124946713 | 12494671 | 17 | C | PL | ACETAMINOPHENCAFFEINEPROMETHAZINESALICYLAMIDE | 1 | Oral | 1 MG, TID | U | U | 0 | 1 | MG | TID | |||||
| 124946713 | 12494671 | 18 | C | NESP | DARBEPOETIN ALFA | 1 | Subcutaneous | 0.5 ML, ONCE | U | U | 0 | .5 | ML | INJECTION | 1X | ||||
| 124946713 | 12494671 | 19 | C | ATEDIO | 2 | Oral | 1 DF, QD | U | U | 0 | 1 | DF | TABLET | QD | |||||
| 124946713 | 12494671 | 20 | C | DIOVAN | VALSARTAN | 1 | Oral | 40 MG, QD | U | U | 0 | 40 | MG | TABLET | QD | ||||
| 124946713 | 12494671 | 21 | C | ARTIST | CARVEDILOL | 1 | Oral | 10 MG, QD | U | U | 0 | 10 | MG | TABLET | QD | ||||
| 124946713 | 12494671 | 22 | C | FRANDOL | ISOSORBIDE DINITRATE | 1 | Transdermal | 40 MG, QD | U | U | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124946713 | 12494671 | 1 | Chronic hepatitis C |
| 124946713 | 12494671 | 2 | Hepatic cirrhosis |
| 124946713 | 12494671 | 3 | Chronic hepatitis C |
| 124946713 | 12494671 | 4 | Hepatic cirrhosis |
| 124946713 | 12494671 | 5 | Constipation |
| 124946713 | 12494671 | 7 | Hypertension |
| 124946713 | 12494671 | 8 | Type 2 diabetes mellitus |
| 124946713 | 12494671 | 9 | Coronary artery bypass |
| 124946713 | 12494671 | 10 | Hyperuricaemia |
| 124946713 | 12494671 | 11 | Hyperlipidaemia |
| 124946713 | 12494671 | 12 | Hypertonic bladder |
| 124946713 | 12494671 | 13 | Hypertension |
| 124946713 | 12494671 | 14 | Hypertension |
| 124946713 | 12494671 | 15 | Hypertension |
| 124946713 | 12494671 | 16 | Cervicobrachial syndrome |
| 124946713 | 12494671 | 17 | Nasopharyngitis |
| 124946713 | 12494671 | 18 | Nephrogenic anaemia |
| 124946713 | 12494671 | 19 | Hypertension |
| 124946713 | 12494671 | 20 | Hypertension |
| 124946713 | 12494671 | 21 | Hypertension |
| 124946713 | 12494671 | 22 | Myocardial ischaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124946713 | 12494671 | OT |
| 124946713 | 12494671 | DS |
| 124946713 | 12494671 | LT |
| 124946713 | 12494671 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124946713 | 12494671 | Anaemia | |
| 124946713 | 12494671 | Blood pressure decreased | |
| 124946713 | 12494671 | Cardio-respiratory arrest | |
| 124946713 | 12494671 | Constipation | |
| 124946713 | 12494671 | Decreased appetite | |
| 124946713 | 12494671 | Malaise | |
| 124946713 | 12494671 | Nasopharyngitis | |
| 124946713 | 12494671 | Nephrogenic anaemia | |
| 124946713 | 12494671 | Pneumonia | |
| 124946713 | 12494671 | Sinus arrest |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124946713 | 12494671 | 1 | 20160107 | 20160217 | 0 | |
| 124946713 | 12494671 | 3 | 20160107 | 20160217 | 0 | |
| 124946713 | 12494671 | 5 | 20160120 | 20160316 | 0 | |
| 124946713 | 12494671 | 6 | 20160316 | 0 | ||
| 124946713 | 12494671 | 10 | 20160316 | 0 | ||
| 124946713 | 12494671 | 13 | 20160224 | 0 | ||
| 124946713 | 12494671 | 16 | 20160120 | 0 | ||
| 124946713 | 12494671 | 17 | 20160203 | 0 | ||
| 124946713 | 12494671 | 18 | 20160217 | 0 | ||
| 124946713 | 12494671 | 19 | 20160224 | 0 | ||
| 124946713 | 12494671 | 20 | 20160224 | 20160302 | 0 | |
| 124946713 | 12494671 | 21 | 20160302 | 0 | ||
| 124946713 | 12494671 | 22 | 20160316 | 0 |